Elevation Oncology, Inc. Profile Avatar - Palmy Investing

Elevation Oncology, Inc.

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-…

Biotechnology
US, New York [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Competitors Table
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of ELEV's Analysis
CIK: 1783032 CUSIP: 28623U101 ISIN: US28623U1016 LEI: - UEI: -
Secondary Listings
ELEV has no secondary listings inside our databases.